The Vasoactive Peptide Angiotensin-(1–7), Its Receptor Mas and the Angiotensin-converting Enzyme Type 2 are Expressed in the Human Endometrium
Authors:
Open Access
- 1 March 2009
- journal article
- research article
- Published by Springer Nature in Reproductive Sciences
- Vol. 16 (3) , 247-256
Abstract
Angiotensin (Ang)-(1-7) is one of the major active components of the renin-angiotensin system, produced from cleavage of Ang II by angiotensin-converting-enzyme type 2 (ACE2), which acts through a specific G protein-coupled receptor, Mas. We have investigated whether the human endometrium expresses these components during menstrual cycle. By radioimmunoassay, Ang-(1-7) was detected in endometrial wash fluid at picomolar concentrations. Using immunofluorescence, both the peptide and its receptor were identified in cultured endometrial epithelial and stromal cells. By immunohistochemistry, Ang(1-7) was localized in the endometrium throughout menstrual cycle, being more concentrated in the glandular epithelium of mid- and late secretory phase. This pattern corresponded to the ACE2 mRNA, which was more abundant in epithelial cells than in stromal cells (2-fold increase, p < 0.05) and in the secretory vs. proliferative phase (6.6-fold increase, p < 0.01). The receptor Mas was equally distributed between epithelial and stromal cells and did not change during menstrual cycle. The physiological role of this peptide system in normal and pathological endometrium warrants further investigation.Keywords
This publication has 41 references indexed in Scilit:
- Angiotensin-(1-7) Counterregulates Angiotensin II Signaling in Human Endothelial CellsHypertension, 2007
- Angiotensin-(1-7) Through Receptor Mas Mediates Endothelial Nitric Oxide Synthase Activation via Akt-Dependent PathwaysHypertension, 2007
- A Place in Our Hearts for the Lowly Angiotensin 1-7 Peptide?Hypertension, 2006
- Molecular Mechanisms of Inhibition of Vascular Growth by Angiotensin-(1-7)Hypertension, 2003
- Antiproliferative Actions of Angiotensin-(1-7) in Vascular Smooth MuscleHypertension, 1999
- Angiotensin-(1–7) Reduces Smooth Muscle Growth After Vascular InjuryHypertension, 1999
- Angiotensin-(1–7) Augments Bradykinin-Induced Vasodilation by Competing With ACE and Releasing Nitric OxideHypertension, 1997
- Angiotensin-(1-7) Inhibits Vascular Smooth Muscle Cell GrowthHypertension, 1996
- Plasma angiotensin(1–7) immunoreactivity is increased by salt load, water deprivation, and hemorrhagePeptides, 1994
- Circulating and tissue angiotensin systems.Journal of Clinical Investigation, 1987